Bruno Aouizerate
Enseignant-chercheur - Praticien hospitalier
PU-PH / Université de Bordeaux/ Contact
+33 5 57 57 12 33
www.orcid.org/0000-0002-7092-7747
Publications
-
Diet quality and associations with lactate and metabolic syndrome in bipolar disorder
Journal of Affective Disorders. 2024-11-01. 364 : 167-177.
10.1016/j.jad.2024.05.167 -
Refining criteria for a neurodevelopmental sub-phenotype of bipolar disorders: a FondaMental Advanced Centers of Expertise for Bipolar Disorders study.
Biological Psychiatry. 2024-10-01.
10.1016/j.biopsych.2024.09.025 -
Management of panic disorder in the elderly.
Geriatr Psychol Neuropsychiatr Vieil .. 2021-10-05.
10.1684/pnv.2021.0965 -
Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder
Psychiatry Research. 2024-09-01. 339 : 116063.
10.1016/j.psychres.2024.116063 -
Does BioAge identify accelerated aging in individuals with bipolar disorder? An exploratory study in the FACE-BD cohort.
Bipolar Disorders. 2024-07-31. 26(6) : 595-603.
10.1111/bdi.13480 -
How is tailored implementation undertaken using a self-guided toolkit? Qualitative study of the ItFits-toolkit in the ImpleMentAll project
Implementation Sci. 2024-07-11. 19(1)
10.1186/s13012-024-01380-w -
Adherence to clinical practice guidelines for using electroconvulsive therapy in elderly depressive patients
BMC Psychiatry. 2024-07-03. 24(1)
10.1186/s12888-024-05933-7 -
Cord serum cytokines at birth and children’s trajectories of mood dysregulation symptoms from 3 to 8 years: The EDEN birth cohort.
Brain, Behavior, & Immunity - Health. 2024-07-01. 38 : 100768.
10.1016/j.bbih.2024.100768 -
Functioning and neurocognition in very early and early-life onset bipolar disorders: the moderating role of bipolar disorder type.
Eur Child Adolesc Psychiatry. 2024-05-03.
10.1007/s00787-024-02372-3 -
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1.
Transl Psychiatry. 2024-03-01. 14(1)
10.1038/s41398-024-02824-z -
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Journal of Affective Disorders. 2024-02-01. 347 : 306-313.
10.1016/j.jad.2023.11.063 -
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.
L'Encéphale. 2024-02-01.
10.1016/j.encep.2023.11.029 -
Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE-BD cohort.
Acta Psychiatr Scand. 2024-01-24.
10.1111/acps.13655 -
Subjects suffering from bipolar disorder taking lithium are less likely to report physical pain: a FACE-BD study.
Eur. Psychiatr.. 2023-12-13. 67(1)
10.1192/j.eurpsy.2023.2476 -
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
European Neuropsychopharmacology. 2023-12-01. 77 : 67-79.
10.1016/j.euroneuro.2023.08.502 -
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1
. 2023-08-04.
10.21203/rs.3.rs-3146080/v1 -
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2023-08-01. 126 : 110779.
10.1016/j.pnpbp.2023.110779 -
Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise – Bipolar Disorder cohort.
Journal of Affective Disorders. 2023-08-01. 335 : 177-185.
10.1016/j.jad.2023.05.017 -
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort
Brain Sciences. 2023-07-24. 13(7) : 1120.
10.3390/brainsci13071120 -
Axo-axonic cells in neuropsychiatric disorders: a systematic review
Front. Cell. Neurosci.. 2023-06-26. 17
10.3389/fncel.2023.1212202 -
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markers.
Journal of Affective Disorders. 2023-05-01. 329 : 369-378.
10.1016/j.jad.2023.02.106 -
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – Data from the FACE-SZ cohort.
Journal of Psychiatric Research. 2023-05-01. 161 : 206-212.
10.1016/j.jpsychires.2023.03.017 -
Clinical characteristics associated with discrepancies between self- and clinician-rated suicidal ideation in patients with bipolar disorder (FACE-BD cohort).
Psychiatry Research. 2023-03-01. 321 : 115055.
10.1016/j.psychres.2023.115055 -
Effectiveness of Self-guided Tailored Implementation Strategies in Integrating and Embedding Internet-Based Cognitive Behavioral Therapy in Routine Mental Health Care: Results of a Multicenter Stepped-Wedge Cluster Randomized Trial.
J Med Internet Res. 2023-02-03. 25 : e41532.
10.2196/41532 -
Associations of white blood cell and platelet counts with specific depressive symptom dimensions in patients with bipolar disorder: Analysis of data from the FACE-BD cohort.
Brain, Behavior, and Immunity. 2023-02-01. 108 : 176-187.
10.1016/j.bbi.2022.12.002 -
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Schizophrenia Research. 2023-02-01. 252 : 48-55.
10.1016/j.schres.2022.12.037 -
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2023-01-01. 120 : 110641.
10.1016/j.pnpbp.2022.110641 -
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.
Eur Arch Psychiatry Clin Neurosci. 2022-07-19. 273(4) : 825-837.
10.1007/s00406-022-01449-x -
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
Front. Psychiatry. 2022-07-01. 13
10.3389/fpsyt.2022.910897 -
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.
Brain, Behavior, & Immunity - Health. 2022-07-01. 22 : 100436.
10.1016/j.bbih.2022.100436 -
Direct medical cost of bipolar disorder: Insights from the FACE-BD longitudinal cohort.
Journal of Affective Disorders. 2022-06-01. 306 : 223-231.
10.1016/j.jad.2022.02.071 -
Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
Eur Arch Psychiatry Clin Neurosci. 2022-04-20. 272(7) : 1273-1282.
10.1007/s00406-022-01384-x -
Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Depression and Anxiety. 2022-03-31. 39(5) : 407-418.
10.1002/da.23257 -
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort study.
Eur Arch Psychiatry Clin Neurosci. 2022-03-25. 272(7) : 1379-1384.
10.1007/s00406-021-01364-7 -
Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022-03-01. 114 : 110479.
10.1016/j.pnpbp.2021.110479 -
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.
International Journal of Neuropsychopharmacology. 2022-02-17. 25(6) : 468-478.
10.1093/ijnp/pyac016 -
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia.
The World Journal of Biological Psychiatry. 2022-02-01. 23(9) : 703-714.
10.1080/15622975.2022.2031286 -
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary study.
Int J Obes. 2022-01-10. 46(4) : 885-888.
10.1038/s41366-021-01049-0 -
Violent suicide attempt history in elderly patients with bipolar disorder: The role of sex, abdominal obesity, and verbal memory: Results from the FACE-BD cohort (FondaMental Advanced center of Expertise for Bipolar Disorders).
Journal of Affective Disorders. 2022-01-01. 296 : 265-276.
10.1016/j.jad.2021.09.097 -
Influence of childhood maltreatment on prevalence, onset and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders.
Eur. Psychiatr.. 2022-01-01. 65(1)
10.1192/j.eurpsy.2022.7 -
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Mol Psychiatry. 2021-12-15. 27(3) : 1286-1299.
10.1038/s41380-021-01381-x -
Relationship between neurocognition and theory of mind as a function of symptomatic profile in schizophrenia: results from the national FACE-SZ cohort.
Cognitive Neuropsychiatry. 2021-12-09. 27(1) : 49-68.
10.1080/13546805.2021.2011184 -
Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics.
Front. Psychiatry. 2021-12-06. 12
10.3389/fpsyt.2021.795666 -
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021-12-01. 111 : 110335.
10.1016/j.pnpbp.2021.110335 -
Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study.
Schizophrenia Bulletin. 2021-10-29. 48(2) : 382-394.
10.1093/schbul/sbab114 -
Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort.
Psychiatry Research. 2021-09-01. 303 : 114044.
10.1016/j.psychres.2021.114044 -
Childhood maltreatment and metabolic syndrome in bipolar disorders: In search of moderators.
Psychoneuroendocrinology. 2021-09-01. 131 : 105327.
10.1016/j.psyneuen.2021.105327 -
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021-08-01. 110 : 110275.
10.1016/j.pnpbp.2021.110275 -
Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes.
Data in Brief. 2021-06-01. 36 : 107004.
10.1016/j.dib.2021.107004 -
The advent of fear conditioning as an animal model of post-traumatic stress disorder: Learning from the past to shape the future of PTSD research
Neuron. 2021-06-01.
10.1016/j.neuron.2021.05.017 -
Outcome prediction with a social cognitive battery: a multicenter longitudinal study.
npj Schizophr. 2021-05-26. 7(1)
10.1038/s41537-021-00160-5 -
Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort✰.
Journal of Affective Disorders. 2021-05-01. 286 : 309-319.
10.1016/j.jad.2021.02.036 -
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates.
Brain, Behavior, and Immunity. 2021-05-01. 94 : 104-110.
10.1016/j.bbi.2021.02.031 -
From gut to brain: Microbiota depletion in mice as a tool to explore causality.
Brain, Behavior, and Immunity. 2021-05-01. 94 : 4-5.
10.1016/j.bbi.2021.02.029 -
Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population.
PLoS ONE. 2021-04-20. 16(4) : e0250148.
10.1371/journal.pone.0250148 -
Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-up.
Journal of Affective Disorders. 2021-03-01. 282 : 812-819.
10.1016/j.jad.2020.12.192 -
Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report.
Journal of Psychiatric Research. 2021-03-01. 135 : 20-27.
10.1016/j.jpsychires.2020.12.055 -
Cord Serum Cytokines at Birth and Children’s Anxiety-Depression Trajectories From 3 to 8 Years: The EDEN Mother-Child Cohort.
Biological Psychiatry. 2021-03-01. 89(6) : 541-549.
10.1016/j.biopsych.2020.10.009 -
Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study.
Journal of Psychiatric Research. 2021-02-01. 134 : 129-137.
10.1016/j.jpsychires.2020.12.041 -
A conceptual framework to develop a patient-reported experience measure of the quality of mental health care: a qualitative study of the PREMIUM project in France.
Journal of Market Access & Health Policy. 2021-01-01. 9(1)
10.1080/20016689.2021.1885789 -
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.
Schizophrenia Bulletin Open. 2021-01-01. 2(1)
10.1093/schizbullopen/sgab012 -
Inflammatory Bases of Neuropsychiatric Symptom Domains: Mechanisms and Specificity.
Immuno-Psychiatry. 2021-01-01. : 335-353.
10.1007/978-3-030-71229-7_20 -
Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort.
Journal of Affective Disorders. 2020-11-01. 276 : 963-969.
10.1016/j.jad.2020.07.078 -
Measuring the Patient Experience of Mental Health Care: A Systematic and Critical Review of Patient-Reported Experience Measures.
PPA. 2020-11-01. Volume 14 : 2147-2161.
10.2147/ppa.s255264 -
Cord Serum Cytokines at Birth and Children’s Anxiety/Depression Trajectories from 3 to 8 Years: The EDEN Mother-Child Cohort
Biological Psychiatry. 2020-10-01.
10.1016/j.biopsych.2020.10.009 -
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
Journal of Affective Disorders. 2020-09-01. 274 : 617-623.
10.1016/j.jad.2020.05.003 -
Guidelines for the design of a virtual patient for psychiatric interview training
J Multimodal User Interfaces. 2020-07-21.
10.1007/s12193-020-00338-8 -
Association between anhedonia and suicidal events in patients with mood disorders: A 3-year prospective study.
Depression and Anxiety. 2020-07-11. 38(1) : 17-27.
10.1002/da.23072 -
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020-07-01. 101 : 109927.
10.1016/j.pnpbp.2020.109927 -
Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode.
Journal of Affective Disorders. 2020-03-01. 264 : 318-323.
10.1016/j.jad.2020.01.004 -
Evaluation of a virtual agent to train medical students conducting psychiatric interviews for diagnosing major depressive disorders
Journal of Affective Disorders. 2020-02-01. 263 : 1-8.
10.1016/j.jad.2019.11.117 -
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
Psychoneuroendocrinology. 2020-02-01. 112 : 104520.
10.1016/j.psyneuen.2019.104520 -
Childhood maltreatment and clinical severity of treatment-resistant depression in a French cohort of outpatients (FACE-DR): One-year follow-up.
Depression and Anxiety. 2020-01-30. 37(4) : 365-374.
10.1002/da.22997 -
Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ database
Brain Behav. 2020-01-07. 10(2)
10.1002/brb3.1495 -
Confirmation of a Two-Factor Solution to the Questionnaire of Cognitive and Affective Empathy in a French Population of Patients With Schizophrenia Spectrum Disorders
Front. Psychiatry. 2019-10-25. 10
10.3389/fpsyt.2019.00751 -
Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study.
J. Clin. Psychiatry. 2019-10-15. 80(6)
10.4088/jcp.19m12755 -
Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.
BMC Psychiatry. 2019-08-28. 19(1)
10.1186/s12888-019-2237-x -
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019-08-01. 94 : 109654.
10.1016/j.pnpbp.2019.109654 -
A Virtual Patient to Train Semiology Extraction and Empathic Communication Skills for Psychiatric Interview
Proceedings of the 19th ACM International Conference on Intelligent Virtual Agents. 2019-07-01.
10.1145/3308532.3329429 -
Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019-06-01. 92 : 226-234.
10.1016/j.pnpbp.2019.01.003 -
Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset
Schizophrenia Research. 2019-06-01. 208 : 90-96.
10.1016/j.schres.2019.04.006 -
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019-06-01. 92 : 8-18.
10.1016/j.pnpbp.2018.12.005 -
Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort
Eur Arch Psychiatry Clin Neurosci. 2019-04-08. 269(5) : 599-610.
10.1007/s00406-019-01001-4 -
A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort
Schizophrenia Research. 2019-02-01. 204 : 38-45.
10.1016/j.schres.2018.07.029 -
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort
Journal of Affective Disorders. 2019-02-01. 245 : 468-474.
10.1016/j.jad.2018.11.004 -
The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice,Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience
L'Encéphale. 2019-02-01. 45(1) : 9-14.
10.1016/j.encep.2018.07.007 -
Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental).
BMC Psychiatry. 2019-01-30. 19(1)
10.1186/s12888-019-2025-7 -
Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
J. Clin. Psychiatry. 2019-01-08. 80(1)
10.4088/jcp.18m12246 -
The Patient-Reported Experience Measure for Improving qUality of care in Mental health (PREMIUM) project in France: study protocol for the development and implementation strategy.
PPA. 2019-01-01. Volume 13 : 165-177.
10.2147/ppa.s172100 -
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
Psychiatry Research. 2018-12-01. 270 : 104-110.
10.1016/j.psychres.2018.09.024 -
Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) scale
Schizophrenia Research. 2018-11-01. 201 : 196-203.
10.1016/j.schres.2018.06.021 -
Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort
Schizophrenia Research. 2018-11-01. 201 : 373-380.
10.1016/j.schres.2018.05.007 -
Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia: The FACE-SZ cohort
J. Clin. Psychiatry. 2018-09-18. 79(6)
10.4088/JCP.17m12007 -
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).
Front. Psychiatry. 2018-07-24. 9
10.3389/fpsyt.2018.00326 -
Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018-07-01. 85 : 62-68.
10.1016/j.pnpbp.2018.04.007 -
Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: Results From the FACE-SZ Cohort.
J. Clin. Psychiatry. 2018-06-27. 79(3)
10.4088/jcp.17m11638 -
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort
Br J Psychiatry. 2018-06-06. 213(2) : 464-470.
10.1192/bjp.2018.87 -
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort
Eur Arch Psychiatry Clin Neurosci. 2018-05-28. 269(8) : 985-992.
10.1007/s00406-018-0908-0 -
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health.
Psychoneuroendocrinology. 2018-05-01. 91 : 55-61.
10.1016/j.psyneuen.2018.02.030 -
Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
Schizophrenia Research. 2018-05-01. 195 : 357-365.
10.1016/j.schres.2017.09.027 -
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
Schizophrenia Research. 2018-05-01. 195 : 529-533.
10.1016/j.schres.2017.08.058 -
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Eur Arch Psychiatry Clin Neurosci. 2018-02-02. 269(4) : 449-457.
10.1007/s00406-018-0873-7 -
Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset.
European Neuropsychopharmacology. 2018-01-01. 28(1) : 24-36.
10.1016/j.euroneuro.2017.11.020 -
Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis.
Journal of Psychiatric Research. 2017-12-01. 95 : 37-45.
10.1016/j.jpsychires.2017.07.013 -
Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).
Front. Psychiatry. 2017-11-24. 8
10.3389/fpsyt.2017.00244 -
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Eur Arch Psychiatry Clin Neurosci. 2017-11-10. 268(6) : 541-553.
10.1007/s00406-017-0847-1 -
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort.
Journal of Psychiatric Research. 2017-11-01. 94 : 62-69.
10.1016/j.jpsychires.2017.06.008 -
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2017-10-01. 79 : 332-339.
10.1016/j.pnpbp.2017.06.026 -
Anterior pallidal deep brain stimulation for Tourette’s syndrome: a randomised, double-blind, controlled trial.
The Lancet Neurology. 2017-08-01. 16(8) : 610-619.
10.1016/s1474-4422(17)30160-6 -
Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
Psychiatry Research. 2017-08-01. 254 : 218-223.
10.1016/j.psychres.2017.04.002 -
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
Schizophrenia Research. 2017-07-01. 185 : 173-181.
10.1016/j.schres.2016.12.021 -
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.
Eur Arch Psychiatry Clin Neurosci. 2017-04-07. 267(6) : 567-577.
10.1007/s00406-017-0779-9 -
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Eur Arch Psychiatry Clin Neurosci. 2017-03-27. 268(1) : 17-26.
10.1007/s00406-017-0787-9 -
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Eur Arch Psychiatry Clin Neurosci. 2017-02-25. 267(5) : 465-472.
10.1007/s00406-017-0771-4 -
Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
Schizophrenia Research. 2016-08-01. 175(1-3) : 161-167.
10.1016/j.schres.2016.04.042 -
Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set
Eur Arch Psychiatry Clin Neurosci. 2016-06-27. 267(6) : 587-594.
10.1007/s00406-016-0708-3 -
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
SCHBUL. 2016-05-03. 42(5) : 1290-1302.
10.1093/schbul/sbw029 -
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
Psychopharmacology. 2015-12-03. 233(4) : 571-578.
10.1007/s00213-015-4167-8 -
Akathisia: Prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
Schizophrenia Research. 2015-12-01. 169(1-3) : 255-261.
10.1016/j.schres.2015.10.040 -
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
Schizophrenia Research. 2015-10-01. 168(1-2) : 388-394.
10.1016/j.schres.2015.07.047 -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.
BMC Cardiovasc Disord. 2015-03-18. 15(1)
10.1186/s12872-015-0015-3 -
Contextual and behavioral influences on uncertainty in obsessive-compulsive disorder.
Cortex. 2015-01-01. 62 : 1-10.
10.1016/j.cortex.2012.12.010 -
Risk factors for treatment resistance in unipolar depression: a systematic review.
Journal of Affective Disorders. 2015-01-01. 171 : 137-141.
10.1016/j.jad.2014.09.020 -
Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate.
European Neuropsychopharmacology. 2014-08-01. 24(8) : 1229-1239.
10.1016/j.euroneuro.2014.05.006 -
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder.
Brain. 2013-01-01. 136(1) : 304-317.
10.1093/brain/aws306 -
The associative and limbic thalamus in the pathophysiology of obsessive-compulsive disorder: An experimental study in the monkey
Transl Psychiatry. 2012-09-01. 2(9) : e161-e161.
10.1038/tp.2012.88 -
Is deep brain stimulation able to make antidepressants effective in resistant obsessive-compulsive disorder?
Biological Psychiatry. 2012-06-01. 71(11) : e43-e44.
10.1016/j.biopsych.2011.10.013 -
Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacy.
Transl Psychiatry. 2011-05-03. 1(5) : e5-e5.
10.1038/tp.2011.5 -
Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia.
Journal of Affective Disorders. 2011-03-01. 129(1-3) : 338-341.
10.1016/j.jad.2010.07.031 -
Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia.
Journal of Affective Disorders. 2011-03-01. 129(1-3) : 338-341.
10.1016/j.jad.2010.07.031 -
A video Clinical Global Impression (CGI) in obsessive compulsive disorder.
Psychiatry Research. 2011-03-01. 186(1) : 117-122.
10.1016/j.psychres.2010.06.021 -
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study.
Biological Psychiatry. 2010-12-01. 68(11) : 1016-1022.
10.1016/j.biopsych.2010.06.033 -
Peritraumatic distress predicts posttraumatic stress symptoms in older people.
Int J Geriat Psychiatry. 2010-11-18. 25(12) : 1306-1307.
10.1002/gps.2445 -
Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex.
Biological Psychiatry. 2010-04-01. 67(7) : e37-e38.
10.1016/j.biopsych.2009.10.007 -
The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms.
Neuroscience. 2010-01-01. 165(2) : 408-417.
10.1016/j.neuroscience.2009.10.043 -
Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis.
Neuropsychopharmacol. 2009-11-04. 35(3) : 686-691.
10.1038/npp.2009.175 -
Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009-06-01. 33(4) : 682-687.
10.1016/j.pnpbp.2009.03.011 -
Lesions in the associative striatum improve obsessive-compulsive disorder.
Biological Psychiatry. 2009-03-01. 65(5) : e11-e13.
10.1016/j.biopsych.2008.10.041 -
Meta-analysis of brain volume changes in obsessive-compulsive disorder.
Biological Psychiatry. 2009-01-01. 65(1) : 75-83.
10.1016/j.biopsych.2008.06.019 -
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.
N Engl J Med. 2008-11-13. 359(20) : 2121-2134.
10.1056/nejmoa0708514 -
Neuronal Correlates of Obsessions in the Caudate Nucleus
Biological Psychiatry. 2008-03-01. 63(6) : 557-562.
10.1016/j.biopsych.2007.06.023 -
Social phobia and premature ejaculation: A case-control study
Depress. Anxiety. 2006-01-01. 23(3) : 153-157.
10.1002/da.20159 -
Deep brain stimulation of the ventral striatum in the treatment of obsessive-compulsive disorder and major depression,Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure
Med Sci (Paris). 2005-10-01. 21(10) : 811-813.
10.1051/medsci/20052110811 -
Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology.
Progress in Neurobiology. 2004-02-01. 72(3) : 195-221.
10.1016/j.pneurobio.2004.02.004